Yew Bio Pharm Balance Sheet - Annual (OTCMKTS:YEWB)

Add to My Stocks
$0.33 $0 (0%) YEWB stock closing price Feb 17, 2017 (Closing)

A thorough fundamental analysis involves using data from Yew Bio Pharm balance sheet, apart from other financial statements, to value the business. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Yew Bio Pharm stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Yew Bio Pharm operating cash flow was $-1.37M while Yew Bio Pharm revenue stood at $29.57M. View latest and last 10 year balance sheet data to check Yew Bio Pharm financial performance..

show more
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011
Marketable Securities-----
Raw Materials3.33M1.44M0.87M0.81M0.45M
Work In Progress--0.01M0.02M0.01M
Finished Goods1.33M-0.19M0.15M0.23M
Notes Receivable-----
Other Current Assets0.17M0.02M0.03M0.06M-
Yew Bio Pharm Total Current Assets
Property Plant & Equipment1.74M1.89M2.01M1.66M1.39M
Accumulated Depreciation1.04M1.03M0.98M0.77M0.61M
Yew Bio Pharm Net Property Plant & Equipment
Investment & Advances-----
Other Non-Current Assets-----
Deferred Charges-----
Deposits & Other Assets12.33M10.66M10.24M9.38M7.5M
Yew Bio Pharm Total Assets
Notes Payable0.6M----
Accounts Payable0.05M---1.36M
Current Portion Long-Term Debt3.84M0.04M4.85M0.04M0.26M
Current Portion Capital Leases-----
Accrued Expenses0.12M0.08M0.13M0.19M0.11M
Income Taxes Payable0.01M0.01M0.01M0.01M-
Other Current Liabilities----0.95M
Yew Bio Pharm Total Current Liabilities
Deferred Taxes/Income-----
Convertible Debt-----
Long-Term Debt-----
Non-Current Capital Leases-----
Other Long-Term Liabilities-----
Yew Bio Pharm Total Liabilities
Minority Interest-----
Preferred Stock-----
Common Stock Net0.05M0.05M0.05M0.05M0.04M
Capital Surplus9.62M8.55M8.05M10.39M7.2M
Retained Earnings25.06M20.44M16.66M13.18M11.46M
Treasury Stock-----
Other Liabilities4.42M5.84M5.54M4.16M3.48M
Yew Bio Pharm Shareholders Equity
Yew Bio Pharm Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Balance sheet for another ticker

Looking at Yew Bio Pharm historical stock prices and the current Yew Bio Pharm stock price can tell you how the stock price has moved, whereas the Yew Bio Pharm PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:
  • Assets: YEWB total assets, which was at $43.81M for 2015 is a balance sheet item representing value of what Yew Bio Pharm owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: The total liabilities of Yew Bio Pharm for 2015 total to $4.64M. Liabilities for a company like Yew Bio Pharm include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Yew Bio Pharm Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover
receivables turnover
PB ratio (
price to book ratio

Annual Balance Sheets For Yew Bio-Pharm Group, Inc. Peers

Fibria Celulose balance sheet, Grow Solutions balance sheet, Pope Resources balance sheet